Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCSD UCSF
- Dates
- study startedestimated completion
- Principal Investigator
- by Rana McKay, M.D. (ucsd)Jonathan Chou, M.D., Ph.D. (ucsf)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientists at UC Cancer
- Rana McKay, M.D. (ucsd)
Associate Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 176 research publications - Jonathan Chou, M.D., Ph.D. (ucsf)
I am a physician-scientist broadly interested in translational oncology and am currently an Instructor in the Division of Hematology/Oncology and postdoctoral research fellow in the Feng Lab (http://fenglaboratory.com/) and Ashworth Lab.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of Michigan Rogel Cancer Center
- ID
- NCT03570619
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 40 study participants
- Last Updated